Personal Genome Diagnostics Raises $75 Million in Series B

Retrieved on: 2018-01-04 02:56:15

Tags for this article:

Business

Health

Biology

Precision medicine

Bristol-Myers Squibb

Personal Genome Diagnostics

Click the tags to see associated articles and topics

Personal Genome Diagnostics Raises $75 Million in Series B. View article details on hiswai:

Excerpt

<div>Pharma heavyweight Bristol-Myers Squibb is the company's newest investor, joining a list that includes <b>New Enterprise Associates</b> (NEA) and a host of venture capital and healthcare investment funds. PGDx specializes in oncology-focused genomics and precision medicine. It says the new funding will ...</div>

Article found on:

View Original Article